T5O0 — bioXXmed AG Cashflow Statement
0.000.00%
Last trade - 00:00- €0.16m
- -€0.09m
- €0.00m
Annual cashflow statement for bioXXmed AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | — | — | — | — |
| Source: | ARS | ||||
| Standards: | — | — | — | — | — |
| Status: | Final | fx Preliminary | fx Preliminary | fx Preliminary | fx Preliminary |
| Net Income/Starting Line | -1.84 | — | — | — | — |
| Depreciation | |||||
| Non-Cash Items | 0.207 | — | — | — | — |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.047 | — | — | — | — |
| Change in Other Assets | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -1.66 | — | — | — | — |
| Capital Expenditures | -0.003 | — | — | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -4.8 | — | — | — | — |
| Purchase of Investments | |||||
| Cash from Investing Activities | -4.8 | — | — | — | — |
| Financing Cash Flow Items | 0 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 6.02 | — | — | — | — |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.44 | — | — | — | — |